EP4010322
FAST FORM (S)-2-(((S)-6,8-DÍFLÚOR-1,2,3,4-TETRAHÝDRÓNAFTALEN-2-ÝL)AMÍNÓ)-N-(1-(2-METÝL-1-(NEÓPENTÝLAMÍNÓ)PRÓPAN-2-ÝL)-1H-IMÍDASÓL-4-ÝL)PENTANAMÍÐS OG NOTKUN ÞESS
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.8.2019EP published:
5.11.2025EP application number:
19758589.6
EP translation filed:
14.1.2026Grant published:
11.2.2026EPO information:
European Patent Register
Max expiry date:
8.8.2039Expiry date:
8.8.2026
Title in English:
SOLID STATE FORMS OF (S)-2-(((S)-6,8-DIFLUORO-1,2,3,4-TETRAHYDRONAPHTHALEN-2-YL)AMINO)-N-(1-(2-METHYL-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE AND USES THEREOFLanguage of the patent:
English
Timeline
Today
9.8.2019EP application
5.11.2025EP Publication
14.1.2026Translation submitted
11.2.2026Registration published
8.8.2026Expires
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Inventor
Name:
GREER, ElaineAddress:
Groton, Connecticut 06340, US
Name:
ANDERSON, StephenAddress:
Stonington, Connecticut 06378, US
Name:
MALONEY, MarkAddress:
Groton, Connecticut 06340, US
Name:
YU, ShuAddress:
Groton, Connecticut 06340, US
Name:
ALBERT, EkaterinaAddress:
West Lafayette, Indiana 47906, US
Name:
RIGSBEE, EmilyAddress:
West Lafayette, Indiana 47906, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Supplementary protection
SPC number:
SPC549
Classification
Categories:
C07D 233/88, A61K 31/4164, A61P 35/00